ArticleLeukemia2026

PLK1 inhibition enhances Brentuximab vedotin efficacy in CD30-positive T-cell lymphoma via spindle assembly checkpoint activation.

Yuto Mori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.